Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Medisca

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    mic“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations  Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support  How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing 

    Impressions: 2531

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/over-500-million-syringes-of-our-hyaluronic-acid-have-been-safely-used-worldwide

    PharmaCompass
    04 Nov 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour API, Our ExpertiseYour API, Our Expertise

    Your API, Our Expertise
    Your API, Our Expertise

    reelYour API, Our Expertise

    This PharmaReel showcases Minakem as a trusted partner for APIs, HPAPIs and steroids from FDA/GMP-certified sites, offering generic & custom solutions and CDMO services from lab to commercial supply, backed by regulatory know-how.

    Impressions: 829

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    The global pharmaceutical excipients market continued to evolve in the third quarter (Q3) of 2025, supported by rising demand for functional excipients, growth in production of generics, and advances in drug delivery technologies. The global market for pharmaceutical excipients was estimated at US$ 9.8 billion to US$ 10.7 billion in 2024, and is projected to grow at a compound annual growth rate (CAGR) of 4.1 to 6.6 percent through 2030. At this pace, the market is expected to reach US$ 13.05 billion to US$ 14.86 billion by 2030. Europe retained the largest market share in 2024, followed by Asia-Pacific. Key drivers shaping the excipients market include the rising prevalence of chronic diseases, expansion of biologics and biosimilars, and increasing quality and regulatory expectations. Increased investments in facility expansions and ongoing reforms in clinical trial regulations are also facilitating market growth. The sector remains highly competitive and fragmented. Major excipient providers include BASF, Roquette, Gangwal Healthcare, DuPont, Evonik, Seqens, SPI Pharma, PMC Isochem, Croda International, Pfanstiehl, Colorcon, Kewpie Corporation, ICE Pharma, Nanjing Well Pharmaceutical, Merck KGaA owned MilliporeSigma, Minakem, Ashland Global, Actylis and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)  Evonik in partnership with Ethris; Colorcon Ventures invests in Phytolon   The market saw strategic collaborations across the excipients and drug formulation ecosystem in Q3 2025. Evonik entered into a partnership with Ethris to strengthen its nucleic acid delivery platform. The collaboration integrates Ethris’ proprietary technology — its lipidoid nanoparticle platform, known as SNaP LNP — into Evonik’s CDMO offerings, enhancing the latter’s ability to support RNA-based therapeutics from concept to clinic. Colorcon Ventures, the investment arm of Colorcon, announced a strategic investment in Israel-based Phytolon. The biotechnology start-up uses precision fermentation to develop natural colorants. The investment underscores Colorcon’s commitment to next-generation coloring technologies that support cleaner-label formulations and innovation in oral solid dosage coatings.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Evonik launches MaxiPure Polysorbate 80; Asahi Kasei expands its portfolio The quarter saw continued innovation in high-purity and injectable-grade excipients. Evonik introduced MaxiPure Polysorbate 80, a high-purity injectable-grade surfactant designed for biologics and parenteral formulations. This excipient addresses key challenges such as protein stability, viral inactivation, and the solubilization of hydrophobic APIs, while meeting regulatory expectations across global markets. Asahi Kasei expanded its Sonanos portfolio of excipients with two new products — Sonanos PG (optimized for sustained release of biologics and peptides while supporting patient-friendly dosing)  and Sonanos DS (developed to enhance solubility of poorly water-soluble APIs). These additions reflect growing industry demand for dosage optimization, stability, and specialized delivery of complex molecules. Gangwal Healthcare operates EXCiPACT-certified GMP facilities and offers a broad range of functional excipients, including co-processed blends like ProBlend, Starlose, and Microlose. Its excipients, including Solvostar (sodium starch glycolate) and Sallyso (croscarmellose sodium), support enhanced tablet disintegration and drug release. The company also provides taste-masking agents such as SucreX (sucralose) and CutCal (neotame), supporting the development of patient-friendly oral dosage forms.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Colorcon, Gattefossé, Croda, Roquette, Clariant expand manufacturing capacities Manufacturing investments and facility expansions remained a key trend during Q3 2025. Colorcon inaugurated a new state-of-the-art, film coating manufacturing facility in Johor, Malaysia. The site incorporates energy-efficient systems and advanced production technologies to strengthen Colorcon’s functional-excipient supply network across Asia. Gattefossé opened a new lipid-based excipient facility in Texas (US), marking a strategic expansion of its North American manufacturing footprint. Croda International expanded its Leek, UK facility with a lipid system synthesis unit and enhanced R&D capabilities. The site will support the launch of Super Refined Poloxamer 188, a highly purified fast-dissolving granular excipient. Roquette announced the opening of a dedicated innovation center in São Paulo, Brazil, strengthening its engagement with regional drug developers. Clariant expanded its Daya Bay, China facility, adding a second spray tower dedicated to pharmaceutical excipient production. The upgraded site increases capacity for excipients used in laxatives and other formulations. BASF also strengthened its commitment to biopharma and pharmaceutical ingredients with a new GMP Solution Center in Michigan (US). The facility expands BASF’s network of poloxamer (a synthetic polymer) manufacturing sites. With state-of-the-art clean room packaging and high-sensitivity analytical testing, this new facility will enable close collaboration with BASF’s customers on customized chemistries for product development.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   India mandates excipient disclosure; new rules to apply from March 2026  India has made it mandatory to disclose excipient details from March 2026 under the country’s new Drugs (2nd Amendment) Rules, 2025. This applies to Schedule H2 medicines. The final notification expands earlier draft requirements by mandating qualitative excipient details in QR codes on product packaging. This should enhance transparency and support patient safety. Meanwhile, US pharmaceutical groups have responded to the US Food and Drug Administration’s draft guidance proposing simplified pathways for replacing color additives in drug products. Industry associations have supported draft guidance, noting that it reduces regulatory burden while maintaining product quality and consistency.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Our view While the fast-growing generics market is creating demand for cost-effective and versatile excipients, the market is also witnessing innovations tailored to the specialized needs of biologics and biosimilars. India is poised to become a key player in the global excipient market, supported by the rapid growth in its generic drug industry, expansion of its health infrastructure and increasing investments in R&D. The new excipient-disclosure rules, therefore, are likely to benefit the global excipient industry by improving transparency and strengthening quality ecosystems.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1443

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-evonik-launches-high-purity-excipients-india-mandates-disclosures-from-march-2026

    #PharmaFlow by PHARMACOMPASS
    20 Nov 2025
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Medisca Settles with FlackTek, strengthens MAZ® Mixer Patent
    Medisca Settles with FlackTek, strengthens MAZ® Mixer Patent

    10 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250610770292/en/Medisca-Secures-Settlement-With-FlackTek-Reinforcing-Patent-Strength-of-MAZ-Mixer

    BUSINESSWIRE
    10 Jun 2025
    Share Share
    Medisca Statement on Settlement With Department of Justice
    Medisca Statement on Settlement With Department of Justice

    01 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241101949692/en

    BUSINESSWIRE
    01 Nov 2024
    Share Share
    Enforcement Report - Week of July 10, 2024
    Enforcement Report - Week of July 10, 2024

    10 Jul 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-10-2024-51523.pdf

    FDA
    10 Jul 2024
    Share Share
    Medisca Opens New Facility to Meet Personalized Medicine Demand
    Medisca Opens New Facility to Meet Personalized Medicine Demand

    27 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240627482773/en

    BUSINESSWIRE
    27 Jun 2024
    Share Share
    Medisca Appoints Sanjay D. Goorachurn As CEO
    Medisca Appoints Sanjay D. Goorachurn As CEO

    16 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240416663563/en

    BUSINESSWIRE
    16 Apr 2024
    Share Share
    Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center
    Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center

    26 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240326567439/en

    BUSINESSWIRE
    26 Mar 2024
    Share Share
    Contact Medisca and get a quotation

    Medisca is a supplier offers 121 products (APIs, Excipients or Intermediates).

    Find a price of Alprostadil bulk offered by Medisca

    Find a price of Altrenogest bulk offered by Medisca

    Find a price of Amitriptyline Hydrochloride bulk offered by Medisca

    Find a price of Amlodipine Besylate bulk offered by Medisca

    Find a price of Anastrozole bulk offered by Medisca

    Find a price of Atropine Sulfate bulk offered by Medisca

    Find a price of Azithromycin Dihydrate bulk offered by Medisca

    Find a price of Baclofen bulk offered by Medisca

    Find a price of Benzocaine bulk offered by Medisca

    Find a price of Betahistine Dihydrochloride bulk offered by Medisca

    Find a price of Bimatoprost bulk offered by Medisca

    Find a price of Bisoprolol Fumarate bulk offered by Medisca

    Find a price of Budesonide bulk offered by Medisca

    Find a price of Bupivacaine Hydrochloride bulk offered by Medisca

    Find a price of Buprenorphine bulk offered by Medisca

    Find a price of Bupropion Hydrochloride bulk offered by Medisca

    Find a price of Chloral Hydrate bulk offered by Medisca

    Find a price of Chlorothiazide bulk offered by Medisca

    Find a price of Clomipramine Hydrochloride bulk offered by Medisca

    Find a price of Clonidine bulk offered by Medisca

    Find a price of Cocaine Hydrochloride bulk offered by Medisca

    Find a price of Dehydroepiandrosterone bulk offered by Medisca

    Find a price of Desonide bulk offered by Medisca

    Find a price of Dextromethorphan Hydrobromide bulk offered by Medisca

    Find a price of Diazoxide bulk offered by Medisca

    Find a price of Diclofenac Sodium bulk offered by Medisca

    Find a price of Doxepin Hydrochloride bulk offered by Medisca

    Find a price of Dutasteride bulk offered by Medisca

    Find a price of Enrofloxacin bulk offered by Medisca

    Find a price of Fampridine bulk offered by Medisca

    Find a price of Fenbendazole bulk offered by Medisca

    Find a price of Fentanyl Citrate bulk offered by Medisca

    Find a price of Finasteride bulk offered by Medisca

    Find a price of Fluconazole bulk offered by Medisca

    Find a price of Fluorouracil bulk offered by Medisca

    Find a price of Flurbiprofen bulk offered by Medisca

    Find a price of Fluticasone Propionate bulk offered by Medisca

    Find a price of Formoterol Fumarate bulk offered by Medisca

    Find a price of Furosemide bulk offered by Medisca

    Find a price of Glipizide bulk offered by Medisca

    Find a price of Guaifenesin bulk offered by Medisca

    Find a price of Hydrocodone Bitartrate bulk offered by Medisca

    Find a price of Itraconazole bulk offered by Medisca

    Find a price of Ivermectin bulk offered by Medisca

    Find a price of Ketoprofen bulk offered by Medisca

    Find a price of Ketorolac Trometamol bulk offered by Medisca

    Find a price of Ketotifen Fumarate bulk offered by Medisca

    Find a price of Lansoprazole bulk offered by Medisca

    Find a price of Leuprolide Acetate bulk offered by Medisca

    Find a price of Levetiracetam bulk offered by Medisca

    Find a price of Levofloxacin bulk offered by Medisca

    Find a price of Lidocaine bulk offered by Medisca

    Find a price of Liothyronine Sodium bulk offered by Medisca

    Find a price of Loratadine bulk offered by Medisca

    Find a price of Meloxicam bulk offered by Medisca

    Find a price of Metformin bulk offered by Medisca

    Find a price of Methimazole bulk offered by Medisca

    Find a price of Methocarbamol bulk offered by Medisca

    Find a price of Methylene Blue bulk offered by Medisca

    Find a price of Metronidazole bulk offered by Medisca

    Find a price of Minoxidil bulk offered by Medisca

    Find a price of Mirtazapine bulk offered by Medisca

    Find a price of Misoprostol bulk offered by Medisca

    Find a price of Mitotane bulk offered by Medisca

    Find a price of Mometasone Furoate bulk offered by Medisca

    Find a price of Mupirocin bulk offered by Medisca

    Find a price of Naloxone Hydrochloride bulk offered by Medisca

    Find a price of Naltrexone Hydrochloride bulk offered by Medisca

    Find a price of Neostigmine Methylsulfate bulk offered by Medisca

    Find a price of Niacinamide bulk offered by Medisca

    Find a price of Omeprazole bulk offered by Medisca

    Find a price of Ondansetron Hydrochloride bulk offered by Medisca

    Find a price of Oxycodone Hydrochloride bulk offered by Medisca

    Find a price of Oxytocin bulk offered by Medisca

    Find a price of Papaverine Hydrochloride bulk offered by Medisca

    Find a price of Paroxetine Hydrochloride bulk offered by Medisca

    Find a price of Pentosan Polysulfate Sodium bulk offered by Medisca

    Find a price of Pentoxifylline bulk offered by Medisca

    Find a price of Pethidine Hydrochloride bulk offered by Medisca

    Find a price of Phenobarbital bulk offered by Medisca

    Find a price of Phenylephrine Hydrochloride bulk offered by Medisca

    Find a price of Phenylpropanolamine Hydrochloride bulk offered by Medisca

    Find a price of Pimobendan bulk offered by Medisca

    Find a price of Polymyxin B Sulfate bulk offered by Medisca

    Find a price of Ponazuril bulk offered by Medisca

    Find a price of Potassium Bromide bulk offered by Medisca

    Find a price of Pramoxine Hydrochloride bulk offered by Medisca

    Find a price of Probenecid bulk offered by Medisca

    Find a price of Progesterone bulk offered by Medisca

    Find a price of Ranitidine Hydrochloride bulk offered by Medisca

    Find a price of Salicylic Acid bulk offered by Medisca

    Find a price of Selegiline Hydrochloride bulk offered by Medisca

    Find a price of Sertraline Hydrochloride bulk offered by Medisca

    Find a price of Sildenafil Citrate bulk offered by Medisca

    Find a price of Sodium Cromoglicate bulk offered by Medisca

    Find a price of Sodium Hyaluronate bulk offered by Medisca

    Find a price of Sodium Phenylbutyrate bulk offered by Medisca

    Find a price of Sodium Valproate bulk offered by Medisca

    Find a price of Sucralfate bulk offered by Medisca

    Find a price of Sulfadiazine bulk offered by Medisca

    Find a price of Sulfamethoxazole bulk offered by Medisca

    Find a price of Tacrolimus bulk offered by Medisca

    Find a price of Terbinafine Hydrochloride bulk offered by Medisca

    Find a price of Testosterone bulk offered by Medisca

    Find a price of Tetracaine bulk offered by Medisca

    Find a price of Tetracaine Hydrochloride bulk offered by Medisca

    Find a price of Thiamine Hydrochloride bulk offered by Medisca

    Find a price of Thyroid bulk offered by Medisca

    Find a price of Tinidazole bulk offered by Medisca

    Find a price of Tizanidine Hydrochloride bulk offered by Medisca

    Find a price of Topiramate bulk offered by Medisca

    Find a price of Tramadol Hydrochloride bulk offered by Medisca

    Find a price of Tranexamic Acid bulk offered by Medisca

    Find a price of Tretinoin bulk offered by Medisca

    Find a price of Trilostane bulk offered by Medisca

    Find a price of Tylosin Tartrate bulk offered by Medisca

    Find a price of Ursodeoxycholic Acid bulk offered by Medisca

    Find a price of Valacyclovir Hydrochloride bulk offered by Medisca

    Find a price of Vitamin B12 bulk offered by Medisca

    Find a price of Vitamin D bulk offered by Medisca

    Find a price of Zonisamide bulk offered by Medisca